Clinical Trials Logo

Clinical Trial Summary

Clinically, all patients with interstitial lung disease were observed, and relevant clinical data were collected. Bronchoscopic specimens were collected according to the condition of the enrolled patients, and the ROSE smear was evaluated, combined with the NGS results of these patients. To observe the etiology and biological characteristics of exacerbation in patients with interstitial lung disease. Patients with apnea should be tested for polysomnography, and corresponding biological specimens should be obtained for molecular biology or other tests


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05838183
Study type Observational
Source Tianjin Medical University General Hospital
Contact Dan Liu
Phone 13920701949
Email liudan_nkdx@163.com
Status Recruiting
Phase
Start date April 1, 2023
Completion date December 31, 2023